close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Shape Therapeutics, Inc.

News headline image
Shape Therapeutics and Rett Syndrome Research Trust Announce Partnership to Advance a One-Time AI-Designed RNA Editing Therapy for Rett Syndrome
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Receives Research Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance SHP-201, a One-Time Gene Therapy to Treat Parkinson’s Disease
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Shares Breakthrough Preclinical Data for Non-Invasive Treatment of Parkinson’s Disease Using a Brain Targeted AAV Gene Therapy at the European Society of Gene & Cell Therapy 32nd Annual Congress
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Unveils Major Advances in AI-Powered Platform for Precision RNA Editing
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Appoints Healthcare Industry Leaders David Epstein and Todd Simpson to its Board of Directors
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics RNAfix® Editing Platform Achieves >90% Editing in Mouse and Non-Human Primate Brain
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
Shape Therapeutics to Showcase RNA Editing in the Brain and Validation of their Stable AAV Producer Cell Line at ASGCT 2024
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing the Potential of Generative AI and RNA in CNS Disorders and Beyond
From Shape Therapeutics, Inc.
Via GlobeNewswire
News headline image
ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference
From Shape Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.